References
- BolardJHow do the polyene macrolide antibiotics affect the cellular membrane-propertiesBiochim Biophys Acta19868643–42573043539192
- HartselSBolardJAmphotericin B: new life for an old drugTrends Pharmacol Sci199617124454499014498
- BrajtburgJBolardJCarrier effects on biological activity of amphotericin BClinical Microbiology Reviews1996945125318894350
- HiemenzJWWalshTJLipid formulations of amphotericin B: Recent progress and future directionsClin Infec Dis199622S1331448722841
- AdamsMLKwonGSRelative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly (N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain lengthJ Control Release2003871–3233212618020
- EgitoESTAraujoIBDamascenoBPriceJCAmphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicityJ Pharm Sci200291112354236612379920
- KleinbergMWhat is the current and future status of conventional amphotericin B?Int J Antimicrob Agents200627Suppl 1S1216
- SelvamSMishraAKDisaggregation of amphotericin B by sodium deoxycholate micellar aggregatesJ Photochem Photobiol B2008932667018725181
- BolardJLegrandPHeitzFCybulskaBOne-sided action of amphotericin-B on cholesterol-containing membranes is determined by its self-association in the mediumBiochemistry19913023570757152043613
- LegrandPRomeroEACohenBEBolardJEffects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytesAntimicrob Agents Chemother19923611251825221489196
- Lamy-FreundMTFerreiraVFNFaljonialarioASchreierSEffect of aggregation on the kinetics of autoxidation of the polyene antibiotic amphotericin-BJ Pharm Sci19938221621668383201
- HartselSCBauerEKwongEHWasanKMThe effect of serum albumin on amphotericin B aggregate structure and activityPharm Res20011891305130911683244
- JunghannsJUButtleIMullerRHSolEmuls technology: A way to overcome the drawback of parenteral administration of insoluble drugsPharm Dev Technol200712543744517963143
- AntoniadouADupontBLipid formulations of amphotericin B: where are we today?J Mycol Med2005154230238
- BekerskyIFieldingRMBuellDLawrenceILipid-based amphotericin B formulations: from animals to manPharm Sci Technol Today19992623023610366838
- JulianoRLGrantCWMBarberKRKalpMAMechanism of the selective toxicity of amphotericin-B incorporated into liposomesMol Pharmacol19873111113807887
- AraujoIBBritoCRUrbanoIASimilarity between the in vitro activity and toxicity of two different fungizone™/lipofundin™ admixturesActa Cir Bras200520Suppl 125726116186987
- SouzaLCMaranhaoRCSchreierSCampaAIn-vitro and in-vivo studies of the decrease of amphotericin-B toxicity upon association with a triglyceride-rich emulsionJ Antimicrob Chemother19933211231328226403
- CheronMPetitCBolardJGaboriauFHeat-induced reformulation of amphotericin B-deoxycholate favours drug uptake by the macrophage-like cell line J774J Antimicrob Chemother200352690491014613963
- GaboriauFCheronMLeroyLBolardJPhysico-chemical properties of the heat-induced ‘super-aggregates’ of amphotericin BBiophys Chem199766111217029866
- GaboriauFCheronMPetitCBolardJHeat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic indexAntimicrob Agents Chemother19974111234523519371331
- HartselSCBaasBBauerEHeat-induced superaggregation of Amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-alphaJ Pharm Sci200190212413311169529
- PetitCYardleyVGaboriauFBolardJCroftSLActivity of a heat-induced reformulation of amphotericin B deoxycholate (Fungizone) against Leishmania donovaniAntimicrob Agents Chemother19994323903929925541
- RogersPDBarkerKSHerringVJacobMHeat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in the human monocytic cell line THP-1J Antimicrob Chemother200351240540812562711
- SivakOBartlettKWasanKMHeat-treated Fungizone retains amphotericin B antifungal activity without renal toxicity in rats infected with Aspergillus fumigatusPharm Res20042191564156615497680
- AraujoIBDamascenoBPde MedeirosTMSoaresLAdo EgitoESDecrease in Fungizone™ toxicity induced by the use of Lipofundin™ as a dilutent: an in vitro studyCurr Drug Deliv20052219920516305421
- BartnerEZinnesHMoeRAKuleskaJSStudies on a new solubilized preparation of amphotericin BAntibiot Annu1957–195855358
- ErnstCDupontGRinnertHLematreJEffect of Temperature- Changes on Circular-Dichroism, Absorption-Spectra and Light- Scattering of Amphotericin-B in Aqueous and Hydro-Alcoholic SolutionsComptes Rendus Hebdomadaires Des Seances De L Academie Des Sciences Serie B197828615175178
- BaasBKindtKScottAScottJMikuleckyPHartselSCActivity and kinetics of dissociation and transfer of amphotericin B from a novel delivery formAAPS Pharm Sci199913E10
- CailletJBergesJLangletJTheoretical study of the self-association of amphotericin BBiochim Biophys Acta1995124021791958541289
- HartselSCBenzSKAyenewWBolardJNa+, K+ and Cl− Selectivity of the permeability pathways induced through sterol-containing membrane-vesicles by amphotericin-B and other polyene antibioticsEur Biophys J19942321251328050397
- BarwiczJChristianSGrudaIEffects of the aggregation state of amphotericin-B on its toxicity to miceAntimicrob Agents Chemother19923610231023151444311
- JolyVFarinottiRSaintjulienLCheronMCarbonCYeniPIn vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin-B (Fungizone) associated with IntralipidAntimicrob Agents Chemother19943821771838192439
- SwensonCEPerkinsWRRobertsPIn vitro and in vivo antifungal activity of amphotericin B lipid complex: Are phospholipases important?Antimicrob Agents Chemother19984247677719559780
- LeonCTaylorRBartlettKHWasanKMEffect of heat-treatment and the role of phospholipases on Fungizone®-induced cytotoxicity within human kidney proximal tubular (HK-2) cells and Aspergillus fumigatusInt J Pharm2005298121121815950412
- van EttenEWvan VianenWRooversPFrederikPMild heating of amphotericin B-desoxycholate: Effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic miceAntimicrob Agents Chemother20004461598160310817715
- BauPBolardJDupouy-CametJHeated amphotericin to treat leishmaniasisLancet Infect Dis20033418812679259
- StoodleyRWasanKABizzottoDFluorescence of Amphotericin B-deoxycholate (Fungizone) monomers and aggregates and the effect of heat-treatmentLangmuir200723178718872517637009